• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Continuous Glucose Monitors (CGM)

Tandem Mobi Integrates with Dexcom G7 CGM, Expanding Choice for Diabetes Management

by Jasmine Pennic 05/29/2024 Leave a Comment

Tandem Mobi Integrates with Dexcom G7 CGM, Expanding Choice for Diabetes Management

What You Should Know:  - Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) systems. - Overall, the Tandem Mobi and Dexcom G7 combination empowers people with diabetes with a discreet, convenient, and technologically advanced solution for managing their condition. Tandem Mobi: Small Pump, Big Choice for Diabetes
Read More

Medicare Expands Coverage for Eversense E3 CGM System, Offering More Options for Diabetes Management

by Jasmine Pennic 02/12/2024 Leave a Comment

Medicare Expands Coverage for Eversense E3 CGM System, Offering More Options for Diabetes Management

What You Should Know: - Medicare has significantly expanded access to the Eversense E3 continuous glucose monitoring (CGM) System, a long-lasting and implantable option that offers several advantages over traditional CGMs. - Medicare has significantly expanded access to the Eversense E3 CGM System, the longest-lasting continuous glucose monitor available, with the implementation of Local Coverage Determinations providing access to implantable CGM for basal-only patients, by the first three
Read More

Ultrahuman Secures $17.5M for Fitness Wearable Glucose Tracker

by Fred Pennic 08/17/2021 Leave a Comment

Ultrahuman Secures $17.5M for Fitness Wearable Glucose Tracker

What You Should Know: - Health tech startup Ultrahuman has raised $17.5 million in Series B funding as it sets out to re-invent fitness-tech via its glucose tracking wearable that helps people improve their diet and exercise. The series B funding came from Alpha Wave Incubation (AWI), which is backed by DisruptAD and managed by Falcon Edge, Steadview Capital, Nexus Venture Partners, Blume Ventures, and Utsav Somani’s iSeed fund. - Founded in 2020 by Mohit Kumar and Vatsal Singhal who were
Read More

Medtronic Receives FDA Approval for New Arm Indication for Continuous Glucose Monitoring System

by Jasmine Pennic 02/26/2018 Leave a Comment

Medtronic Receives FDA Approval for New Arm Indication for Continuous Glucose Monitoring System

Medtronic today announced that the FDA has approved a new arm indication for the Guardian Sensor 3, the company’s most accurate continuous glucose monitoring system and the only sensor approved in the U.S. to help control automated insulin delivery for patient with diabetes via its hybrid closed loop system – the MiniMed 670G system.This expanded indication will enable patients to wear the sensor on the upper arm, providing improved flexibility, enhanced performance for users, as well as
Read More

Medtronic Integrates With Fitbit to Understand How Exercise Impacts Glucose Levels

by Fred Pennic 12/07/2016 Leave a Comment

Medtronic Integrates with Fitbit to Understand How Exercise Impacts Glucose Levels

Medtronic has announced a partnership with connected health provider Fitbit to integrate health and activity tracking to physicians and care teams for patients living with diabetes. With this integration, patients with Type 2 diabetes will be able to monitor their glucose levels and physical activity data via Medtronic's iPro(TM)2 myLog mobile app. Together, the partnership will provide meaningful insight on how exercise impacts glucose levels for more effective diabetes care
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

2026 Predictions & Trends

Healthcare 2026 Forecast: Executives on AI Survival, Financial Reckoning, and the End of Point Solutions

2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over

Most-Read

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

KLAS Report: Why Hospitals Are Choosing Efficiency Over 'Agentic' AI Hype in 2025

KLAS Report: Why Hospitals Are Choosing Efficiency Over ‘Agentic’ AI Hype in 2025

Advanced Primary Care 2026: Top 6 Investments for Health Systems According to Harvard Medical School

Advanced Primary Care 2026: Top 6 Investments for Health Systems According to Harvard Medical School

AI Nutrition Labels: The Key to Provider Adoption and Patient Trust?

AI Nutrition Labels: The Key to Provider Adoption and Patient Trust?

Kristen Hartsell, VP of Clinical Services, RedSail Technologies

The Pharmacy Closures Crisis: How Independent Pharmacies Are Fixing Pharmacy Deserts

HHS Launches 'OneHHS' AI Strategy to Integrate AI Across CDC, CMS, and FDA for Efficiency and Public Trust

HHS Launches ‘OneHHS’ AI Strategy to Integrate AI Across CDC, CMS, and FDA for Efficiency and Public Trust

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags

The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags

Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation

Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation

AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement

AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |